201 related articles for article (PubMed ID: 28675028)
1. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z
ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028
[TBL] [Abstract][Full Text] [Related]
2. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice.
Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z
ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045
[TBL] [Abstract][Full Text] [Related]
3. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo.
Chen J; He H; Deng C; Yin L; Zhong Z
Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364
[TBL] [Abstract][Full Text] [Related]
4. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
[TBL] [Abstract][Full Text] [Related]
5. pH-Sensitive Coiled-Coil Peptide-Cross-Linked Hyaluronic Acid Nanogels: Synthesis and Targeted Intracellular Protein Delivery to CD44 Positive Cancer Cells.
Ding L; Jiang Y; Zhang J; Klok HA; Zhong Z
Biomacromolecules; 2018 Feb; 19(2):555-562. PubMed ID: 29284258
[TBL] [Abstract][Full Text] [Related]
6. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
7. Small, Traceable, Endosome-Disrupting, and Bioresponsive Click Nanogels Fabricated via Microfluidics for CD44-Targeted Cytoplasmic Delivery of Therapeutic Proteins.
Huang K; He Y; Zhu Z; Guo J; Wang G; Deng C; Zhong Z
ACS Appl Mater Interfaces; 2019 Jun; 11(25):22171-22180. PubMed ID: 31190543
[TBL] [Abstract][Full Text] [Related]
8. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
9. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
[TBL] [Abstract][Full Text] [Related]
10. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted and nitric oxide-generated nanogels of keratin and hyaluronan for enhanced cancer therapy.
Sun Z; Yi Z; Cui X; Chen X; Su W; Ren X; Li X
Nanoscale; 2018 Jul; 10(25):12109-12122. PubMed ID: 29915821
[TBL] [Abstract][Full Text] [Related]
12. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
[TBL] [Abstract][Full Text] [Related]
13. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
[TBL] [Abstract][Full Text] [Related]
14. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
15. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
16. Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer.
Xi X; Lei F; Gao K; Li J; Liu R; Karpf AR; Bronich TK
J Control Release; 2023 Aug; 360():872-887. PubMed ID: 37478915
[TBL] [Abstract][Full Text] [Related]
17. CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice.
Zhong Y; Meng F; Zhang W; Li B; van Hest JCM; Zhong Z
J Control Release; 2020 Apr; 320():421-430. PubMed ID: 32027936
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
19. Tailor-Making Fluorescent Hyaluronic Acid Microgels via Combining Microfluidics and Photoclick Chemistry for Sustained and Localized Delivery of Herceptin in Tumors.
Chen J; Huang K; Chen Q; Deng C; Zhang J; Zhong Z
ACS Appl Mater Interfaces; 2018 Jan; 10(4):3929-3937. PubMed ID: 29302970
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic Acid-Shelled Disulfide-Cross-Linked Nanopolymersomes for Ultrahigh-Efficiency Reactive Encapsulation and CD44-Targeted Delivery of Mertansine Toxin.
Zhang Y; Wu K; Sun H; Zhang J; Yuan J; Zhong Z
ACS Appl Mater Interfaces; 2018 Jan; 10(2):1597-1604. PubMed ID: 29272095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
